Abstract
AbstractMulti-locus signatures of blood-based DNA methylation are well-established biomarkers for lifestyle and health outcomes. Here, we focus on two CpGs that are strongly associated with age and smoking behaviour. Imputing these loci via epigenome-wide CpGs results in stronger associations with outcomes in external datasets compared to directly measured CpGs. If extended epigenome-wide, CpG imputation could augment historic arrays and recently-released, inexpensive but lower-content arrays, thereby yielding better-powered association studies.
Publisher
Cold Spring Harbor Laboratory
Reference27 articles.
1. Genome-wide DNA methylation profiling using Infinium® assay
2. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling
3. Infinium HumanMethylation450 BeadChip Product Files. Data Sheet. https://www.illumina.com/content/dam/illumina-marketing/documents/products/datasheets/datasheet_humanmethylation450.pdf [accessed 06 August 2024].
4. Infinium MethylationEPIC v2.0 Kit BeadChip, Data Sheet. https://emea.illumina.com/content/dam/illumina/gcs/assembled-assets/marketing-literature/infinium-methylation-epic-data-sheet-m-gl-01156/infinium-methylation-epic-data-sheet-m-gl-01156.pdf [accessed 06 August 2024].
5. DNA co-methylation has a stable structure and is related to specific aspects of genome regulation